Rare diseases
Investigational molecules
Locations
Back to Germany30 clinical trials in Hildesheim, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on various breast cancer subtypes, including HR-positive, HER2-positive, and triple-negative breast cancer. Studies evaluate new therapeutic approaches combining targeted therapies with standard treatments.
Multiple trials investigating innovative treatments like ribociclib, elacestrant, and trastuzumab deruxtecan.
Groundbreaking research in hematologic malignancies, including chronic lymphocytic leukemia, acute myeloid leukemia, and Hodgkin lymphoma. Trials focus on improving treatment outcomes through targeted therapies.
Studies evaluate innovative drug combinations and personalized treatment durations.
Advanced research in colorectal cancer treatment, focusing on both colon and rectal cancers. Studies examine pre-operative treatments and novel therapeutic strategies.
Trials investigate customized treatment approaches based on disease staging and molecular markers.
Innovative trials in ovarian cancer treatment, exploring new therapeutic combinations and maintenance strategies. Research focuses on improving outcomes for newly diagnosed cases.
Studies evaluate novel drug combinations including niraparib and bevacizumab.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
